Peptide-Receptor Binding Kinetics
Understanding kon and koff rates, residence time, and kinetic selectivity in peptide-receptor interactions and their implications for drug design.
Table of Contents
Peptide-Receptor Binding Kinetics
Binding affinity (Kd) is the most commonly reported parameter for peptide-receptor interactions, but it describes only the equilibrium state. Kinetic parameters provide deeper insight into how peptides interact with receptors and predict in vivo behavior.
Association and Dissociation Rates
kon (Association Rate Constant)
kon describes how quickly a peptide binds its receptor, measured in M-1 s-1. Typical values range from 10^5 to 10^8 M-1 s-1. Association rates are often diffusion-limited, meaning they reflect how fast the peptide encounters and recognizes the binding site.
Factors affecting kon:
- Peptide diffusion coefficient
- Electrostatic complementarity at the binding interface
- Conformational flexibility of both peptide and receptor
koff (Dissociation Rate Constant)
koff describes how quickly the peptide-receptor complex dissociates, measured in s-1. Values range widely from 10^-1 to 10^-5 s-1. Slow koff rates indicate prolonged receptor engagement.
Mnemonic: “koff = kicked off” - how fast the peptide gets kicked off the receptor.
Residence Time
Residence time (tau) equals 1/koff and represents the average duration a peptide remains bound to its receptor. Longer residence times often correlate with greater pharmacological effect because:
- Sustained receptor engagement maintains signaling
- The peptide may be protected from degradation while bound
- Receptor internalization kinetics are influenced by occupancy duration
Kinetic Selectivity
Two peptides may have identical Kd values but very different kinetic profiles. Kinetic selectivity exploits these differences:
- Peptide A: kon = 10^7 M-1 s-1, koff = 10^-2 s-1, Kd = 1 nM
- Peptide B: kon = 10^5 M-1 s-1, koff = 10^-4 s-1, Kd = 1 nM
Both have the same affinity, but Peptide B has 100-fold longer residence time. In vivo, Peptide B may produce a more sustained therapeutic effect.
Implications for Drug Design
Optimizing kinetics rather than just affinity can improve drug performance. Slow koff rates are particularly valuable for antagonists where sustained receptor blockade is desired.
Learning Tip
When evaluating peptide candidates, measure both kon and koff in addition to Kd. A peptide with moderate affinity but slow dissociation may outperform a high-affinity peptide with fast kinetics in functional assays.